Get started
Author

Sarah E. Podwika

Observed names: Podwika, Sarah, Sarah Podwika
ORCID: 0000-0002-5978-8678
Observed ORCID: 0000-0002-5978-8678
OpenAlex ID: A5010678564
TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes
2023 · Karley Whelan, Mairead Dillon, et al. · Gynecologic Oncology · 36
Top advances of the year: Cervical cancer
2024 · Linda R. Duska, Sarah E. Podwika, et al. · Cancer · 35
Top advances of the year: Cervical cancer
2023 · Sarah E. Podwika, Linda R. Duska · Cancer · 25
Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young?
2020 · Sarah E. Podwika, Taylor M. Jenkins, et al. · Gynecologic Oncology Reports · 10
PDF
Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability
2025 · Bradley R. Corr, Samantha M. Thomas, et al. · Gynecologic Oncology · 7
The potential for opportunistic salpingectomy to reduce ovarian cancer in women undergoing non-gynecologic surgery
2025 · Ian C. Cook, Sarah E. Podwika, et al. · Gynecologic Oncology Reports · 7
Enhanced Recovery After Urogynecologic Surgery: A Survey of Patient Experience
2021 · Elisa R. Trowbridge, Sarah L. Evans, et al. · Urogynecology · 5
Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)
2025 · Sarah S. Lee, Angeles Alvarez Secord, et al. · Gynecologic Oncology · 3
The role of pulmonary resection in the management of metastatic gestational trophoblastic neoplasia: Two cases of durable remission following surgery for chemo-resistant disease
2019 · Jeanine N. Staples, Sarah Podwika, et al. · Gynecologic Oncology Reports · 3
PDF
When ovarian mature teratoma peritonitis mimics cancer: What is the best treatment?
2024 · Madison Klavans, Sarah E. Podwika, et al. · Gynecologic Oncology Reports · 1
Trends in reimbursement for minimally invasive gynecologic surgery
2024 · Sarah Podwika, Malavika Kesavan, et al. · Gynecologic Oncology · 1
Clinical outcomes patients with high tumor mutational burden, high microsatellite stability, and mismatch repair deficiency in a multi-institutional endometrial cancer consortium (029)
2023 · Sarah Lee, Angeles Alvarez Secord, et al. · Gynecologic Oncology · 1
PDF
Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)
2026 · Ko, Emily, Bisht, Nikita, et al. · UNC Libraries
MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
2026 · Lindsay E. Borden, Casey M. Cosgrove, et al. · Gynecologic Oncology
Racial and Ethnic Differences and Clinical Outcomes of Patients with High Tumor Mutational Burden, High Microsatellite Instability, and Mismatch Repair Deficiency: Real-World Data from the Multi-Institutional Endometrial Cancer Molecularly Targeted Therapy Consortium (Ecmt2)
2025 · Sarah S. Lee, Angeles Alvarez Secord, et al. · SSRN Electronic Journal
Trends in benign hysterectomies performed by gynecologic oncologists, 2015–2021: A National Surgical Quality Improvement Program (NSQIP) analysis
2024 · Annalyn Welp, Mark Smolkin, et al. · Gynecologic Oncology
Impact of COVID-19 pandemic on stage of gynecologic cancers at presentation and time to treatment
2024 · Ester Goldfeld, Sarah Podwika, et al. · Gynecologic Oncology
Immune checkpoint inhibition for mismatch repair deficient endometrial cancer: MLH1 hypermethylation does not impact outcome in a multi-institutional retrospective database
2024 · Lindsay Borden, Christina Washington, et al. · Gynecologic Oncology
PR023/#503 Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability
2023 · Bradley Corr, Samantha Thomas, et al. · International Journal of Gynecological Cancer
PDF
Keeping up with inflation? Trends in gynecologic oncology medicare surgical reimbursement over the past twenty years (016)
2023 · Sarah Podwika, Malavika Kesavan · Gynecologic Oncology
PDF
Preoperative and Perioperative Analgesia/Anesthesia in Ovarian Cancer Patients: Correlation With Recurrence [36H]
2020 · Sarah Podwika, Allison Bosch, et al. · Obstetrics and Gynecology
Multidisciplinary Management of Morbidly Adherent Placenta Reduces Blood Loss [38N]
2019 · Sarah Podwika, Connor Wang, et al. · Obstetrics and Gynecology
Physical Activity, Nutrition and Hormone Levels of Postmenopausal Women With and Without Endometrial Cancer [40R]
2019 · Sarah Podwika, Anne Gabel, et al. · Obstetrics and Gynecology
Works count: 23
Citation count: 130
H-index: 6
I10-index: 4
Year
Topic
Type